STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Adaptive Biotechnologies Corp

Filed

November 20, 2023

Period of Report

November 16, 2023

Accession Number

0001062993-23-021224